What is HC Wainwright’s Estimate for VNDA Q1 Earnings?

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Vanda Pharmaceuticals in a research report issued to clients and investors on Tuesday, February 18th. HC Wainwright analyst R. Selvaraju expects that the biopharmaceutical company will earn ($0.08) per share for the quarter. […]